<--- Back to Details
First PageDocument Content
Protease inhibitors / Antivirals / Cytokines / Hepatitis / Viral hepatitis / Hepatitis C / Peginterferon alfa-2a / Telaprevir / Boceprevir / Medicine / Biology / Health
Date: 2014-07-25 10:26:12
Protease inhibitors
Antivirals
Cytokines
Hepatitis
Viral hepatitis
Hepatitis C
Peginterferon alfa-2a
Telaprevir
Boceprevir
Medicine
Biology
Health

SUPPLEMENT ARTICLE Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs Geert Robaeys,1,2,3,a Jason Grebely,4,a Stefan Mauss,5 Philip Bruggmann,6 Joseph Moussalli,7,8 Andrea De

Add to Reading List

Source URL: www.hepatitis-c-initiative.eu

Download Document from Source Website

File Size: 165,39 KB

Share Document on Facebook

Similar Documents

Treatment of Chronic Hepatitis C - January 2016 Update (The changes compared to the November 2015 Update are highlighted in yellow) Swiss Association for the Study of the Liver and Swiss Society for Infectious Diseases

Treatment of Chronic Hepatitis C - January 2016 Update (The changes compared to the November 2015 Update are highlighted in yellow) Swiss Association for the Study of the Liver and Swiss Society for Infectious Diseases

DocID: 1qOAQ - View Document

NIH Public Access Author Manuscript Haemophilia. Author manuscript; available in PMC 2015 September 01. NIH-PA Author Manuscript

NIH Public Access Author Manuscript Haemophilia. Author manuscript; available in PMC 2015 September 01. NIH-PA Author Manuscript

DocID: 1qx0K - View Document

Treatment of Chronic Hepatitis C - January 2016 Update (The changes compared to the November 2015 Update are highlighted in yellow) Swiss Association for the Study of the Liver and Swiss Society for Infectious Diseases

Treatment of Chronic Hepatitis C - January 2016 Update (The changes compared to the November 2015 Update are highlighted in yellow) Swiss Association for the Study of the Liver and Swiss Society for Infectious Diseases

DocID: 1qfUf - View Document

Transplantologiya – 2015. – № 1. – P. 13–22. The use of telaprevir for the treatment of hepatitis C in patients undergoing liver transplantation (Literature review and clinical experience) M.Sh. Khubutiya1, V.E

DocID: 1ngSx - View Document

Microsoft PowerPoint - PHT SLA Spring 2012_ClinicalTrials_WEB.pptx

Microsoft PowerPoint - PHT SLA Spring 2012_ClinicalTrials_WEB.pptx

DocID: 1msHW - View Document